SWACH Expands Naloxone Access With Intramuscular Option

SWACH is expanding naloxone access by now offering some intramuscular (IM) naloxone in addition to intranasal (IN) naloxone, also known as nasal spray. This update gives community members and partners another option for overdose prevention and response, while continuing to support access to both forms of this life-saving medication.

People can expect to begin seeing IM naloxone in select locations, including XChange Recovery, Recovery Café, and the Clark County Jail.

According to Sashila Mistiuk, SWACH’s Community Health Improvement Program Senior Manager, expanding the types of naloxone available is part of a broader harm reduction approach.

“The expansion of overdose prevention supplies, and naloxone administration modality, in vending machines is an evidence-based harm reduction approach to giving individuals the option to choose from a broad range of supplies to keep them safe,” Mistiuk said.

Naloxone is a medication that can reverse an opioid overdose. It commonly comes in two forms: intranasal naloxone, which is sprayed into the nose, and intramuscular naloxone, which is given as a shot into the muscle. Both are safe options. The most important thing is that naloxone is available and that people feel prepared to use the form they have.

Adding IM naloxone does not replace nasal spray. Instead, it gives people more choice in how they access and use overdose prevention supplies. This can be especially important in community settings where people may have different comfort levels, training, or practical needs.

Mistiuk said one common concern is the use of needles in clinical settings.

“Many have concerns about the safety of usage of needles,” she said.

That is one reason education remains important as naloxone access expands. Helping people understand the difference between IM and IN naloxone, how each is used, and why both are safe can reduce confusion and support greater confidence in overdose response.

By offering both intranasal and intramuscular naloxone, SWACH is continuing to support a practical, community-centered approach to overdose prevention, one that focuses on access, safety, and meeting people where they are.

Previous
Previous

Recognizing the recipients of the Klickitat Opioid Settlement Funds

Next
Next

Betsy Larson named SWACH Executive Director